Germany-based biotechnology company Sphingotec has introduced a simple blood test to quantify individual risk of developing breast cancer in women. The test, sphingotest pro-NT, enables gynecologists, family doctors and clinical ...
Tags: Germany, Sphingotec, blood test, individual risk, breast cancer